Wednesday, March 10, 10 a.m. ET
The 3TR IMI project consortium and Critical Path Institute invite you to participate in the IBD Biomarker Regulatory Science Webinar. Together, with a collection of public research institutes, industry members and patient advocates, we will align on how to progress biomarkers through the FDA & EMA’s regulatory acceptance process. This webinar will include key stakeholders from the IBD medical community focused on establishing a partnership to facilitate the progression of IBD biomarkers through regulatory acceptance.
To view all the pre-recorded presentations and panel discussions, visit: https://c-path.org/ibd-biomarker-regulatory-science-webinar/.